🇺🇸 FDA

Intelligence · Patent portfolio

RIGEL PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for RIGEL PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
373
Expiring ≤24m
18

Quick answer

RIGEL PHARMACEUTICALS has 373 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 18 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 8

  1. US 9981944

    GDF-8 inhibitors

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9920041

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9913843

    Protein kinase C inhibitors and uses thereof

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9913842

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9890144

    Compounds and method for treating autoimmune diseases

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9884868

    TGF-beta inhibitors

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9878992

    GDF-8 inhibitors

    Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9845512

    Screening assay employing Dex and GDF8

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9845311

    Nrf2 activating compounds and uses thereof

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9834568

    Kinase inhibitors and their uses

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9751893

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9737554

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9732070

    Protein kinase C inhibitors and uses thereof

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9732073

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9730930

    Treatment for vitiligo

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9725419

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9701647

    Tetrazolones as a carboxylic acid bioisosteres

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9682976

    Protein kinase C inhibitors and uses thereof

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9663496

    AMPK-activating heterocyclic compounds and methods for using the same

    Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9650391

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9644224

    Methods for cyclizing synthetic polymers

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9624229

    Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9611260

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9598432

    2,4-pyrimidinediamine compounds and uses as anti-proliferative agents

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9593082

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9586908

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9566283

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9566278

    Protein kinase C inhibitors and uses thereof

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9540334

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9532998

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9518040

    GDF-8 inhibitors

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9511058

    Methods for using carboxamide, sulfonamide and amine compounds

    Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9499493

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9481654

    Compositions and methods for inhibition of the JAK pathway

    Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9475781

    Fumarate analogs and uses thereof

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9453028

    Protein kinase C inhibitors and uses thereof

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9439888

    Tetrazolones as a carboxylic acid bioisosteres

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9416112

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9409884

    5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9353111

    Carboxamide compounds and methods for using the same

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9353124

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9353112

    Synthesis of polycyclic alkaloids

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9353126

    Substituted triazoles useful as Axl inhibitors

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9346765

    2,4-pyrimidinediamine compounds and their uses

    Expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9321763

    Protein kinase C inhibitors and uses thereof

    Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9283238

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9266912

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9266856

    AMPK—activating heterocyclic compounds and methods for using the same

    Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does RIGEL PHARMACEUTICALS have?

373 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do RIGEL PHARMACEUTICALS patents expire?

18 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.